Literature DB >> 11128304

Monte Carlo dosimetry of a new 192Ir high dose rate brachytherapy source.

A Angelopoulos1, P Baras, L Sakelliou, P Karaiskos, P Sandilos.   

Abstract

This work provides full dosimetric data for a new high-strength 192Ir source currently launched by Varian Oncology Systems for use in their high dose rate remote afterloading systems. The active core length of the new source is reduced to 5 mm compared to a value of 10 mm for the existing VariSource source design, with all other geometric source and encapsulation details being similar. Dose-rate constant, radial dose functions, geometry factors, and anisotropy functions, utilized in the AAPM Task Group 43 dose calculation formalism, were calculated using Monte Carlo simulation. Results are compared with corresponding data published for the existing VariSource and microSelectron high dose rate sources. The dose-rate constant for the new Varian source was found to be equal to 1.101 +/- 0.006cGyh(-1) U(-1), compared to values of 1.043 +/- 0.005 and 1.116 +/- 0.006 cGyh(-1) U(-1) calculated for the existing VariSource and microSelectron sources, respectively. The radial dose functions between the three sources are similar with the exception of their values at radial distances very close to the source (r approximately 2 mm) where differences of approximately 3% are observed. The new Varian source demonstrates a smaller anisotropy relative to the existing VariSource source design for polar angles close to the source longitudinal axis, due to its smaller active core length.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11128304     DOI: 10.1118/1.1315316

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  19 in total

1.  Dosimetric characteristics of the ¹⁹²Ir high-dose-rate afterloading brachytherapy source.

Authors:  Mahdi Sadeghi; Fatemah Taghdiri; Pooneh Saidi
Journal:  Jpn J Radiol       Date:  2011-06-30       Impact factor: 2.374

2.  Current state of the art brachytherapy treatment planning dosimetry algorithms.

Authors:  P Papagiannis; E Pantelis; P Karaiskos
Journal:  Br J Radiol       Date:  2014-07-16       Impact factor: 3.039

3.  Dosimetric characterization and output verification for conical brachytherapy surface applicators. Part I. Electronic brachytherapy source.

Authors:  Regina K Fulkerson; John A Micka; Larry A DeWerd
Journal:  Med Phys       Date:  2014-02       Impact factor: 4.071

4.  Impact of heterogeneity-based dose calculation using a deterministic grid-based Boltzmann equation solver for intracavitary brachytherapy.

Authors:  Justin K Mikell; Ann H Klopp; Graciela M N Gonzalez; Kelly D Kisling; Michael J Price; Paula A Berner; Patricia J Eifel; Firas Mourtada
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-19       Impact factor: 7.038

5.  Determination of exit skin dose for 192Ir intracavitary accelerated partial breast irradiation with thermoluminescent dosimeters.

Authors:  Julie A Raffi; Stephen D Davis; Cliff G Hammer; John A Micka; Keith A Kunugi; Jana E Musgrove; John W Winston; Terresa J Ricci-Ott; Larry A DeWerd
Journal:  Med Phys       Date:  2010-06       Impact factor: 4.071

6.  Efficient 169 Yb high-dose-rate brachytherapy source production using reactivation.

Authors:  Ryan T Flynn; Quentin E Adams; Karolyn M Hopfensperger; Xiaodong Wu; Weiyu Xu; Yusung Kim
Journal:  Med Phys       Date:  2019-05-27       Impact factor: 4.071

7.  169 Yb-based rotating shield brachytherapy for prostate cancer.

Authors:  Quentin Adams; Karolyn M Hopfensperger; Yusung Kim; Xiaodong Wu; Ryan T Flynn
Journal:  Med Phys       Date:  2020-11-01       Impact factor: 4.506

8.  Dose distributions of an ¹⁹²Ir brachytherapy source in different media.

Authors:  C H Wu; Y J Liao; Y W Hsueh Liu; S K Hung; M S Lee; S M Hsu
Journal:  Biomed Res Int       Date:  2014-04-07       Impact factor: 3.411

9.  Evaluation of wall correction factor of INER's air-kerma primary standard chamber and dose variation by source displacement for HDR ¹⁹²Ir brachytherapy.

Authors:  J H Lee; J N Wang; T T Huang; S H Su; B J Chang; C H Su; S M Hsu
Journal:  Biomed Res Int       Date:  2013-10-08       Impact factor: 3.411

10.  Dosimetry of indigenously developed (192)Ir high-dose rate brachytherapy source: An EGSnrc Monte Carlo study.

Authors:  Sridhar Sahoo; T Palani Selvam; S D Sharma; Trupti Das; A C Dey; B N Patil; K V S Sastri
Journal:  J Med Phys       Date:  2016 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.